Author: Morán Blanco, Juan Ignacio; Alvarenga Bonilla, Judith A.; Homma, Sakae; Suzuki, Kazuo; Fremont-Smith, Philip; Villar Gómez de las Heras, Karina
Title: Antihistamines and azithromycin as a treatment for COVID-19 on primary health care – A retrospective observational study in elderly patients Cord-id: mqk72say Document date: 2021_1_16
ID: mqk72say
Snippet: Between March and April 2020, 84 elderly patients with suspected COVID-19 living in two nursing homes of Yepes, Toledo (Spain) were treated early with antihistamines (dexchlorpheniramine, cetirizine or loratadine), adding azithromycin in the 25 symptomatic cases. The outcomes are retrospectively reported. The primary endpoint is the fatality rate of COVID-19. The secondary endpoints are the hospital and ICU admission rates. Endpoints were compared with the official Spanish rates for the elderly.
Document: Between March and April 2020, 84 elderly patients with suspected COVID-19 living in two nursing homes of Yepes, Toledo (Spain) were treated early with antihistamines (dexchlorpheniramine, cetirizine or loratadine), adding azithromycin in the 25 symptomatic cases. The outcomes are retrospectively reported. The primary endpoint is the fatality rate of COVID-19. The secondary endpoints are the hospital and ICU admission rates. Endpoints were compared with the official Spanish rates for the elderly. The mean age of our population was 85 and 48% were over 80 years old. No hospital admissions, deaths, nor adverse drug effects were reported in our patient population. By the end of June, 100% of the residents had positive serology for COVID-19. Although clinical trials are needed to determine the efficacy of both drugs in the treatment of COVID-19, this analysis suggests that primary care diagnosis and treatment with antihistamines, plus azithromycin in selected cases, may treat COVID-19 and prevent progression to severe disease in elderly patients.
Search related documents:
Co phrase search for related documents- action mechanism and admission require: 1
- action mechanism and low concentration: 1, 2, 3, 4
- action mechanism and low incidence: 1
- action mechanism and lung damage: 1, 2, 3, 4, 5, 6
- action mechanism and lung epithelial cell: 1, 2
- action mechanism and lung virus load: 1
- acute death respiratory distress syndrome and admission rate: 1, 2
- acute death respiratory distress syndrome and admission require: 1, 2
- acute death respiratory distress syndrome and lung damage: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- acute death respiratory distress syndrome and lung epithelial cell: 1, 2
- admission rate and low fatality: 1
- admission rate and low fatality rate: 1
- admission rate and low incidence: 1, 2, 3
- admission rate and low morbidity: 1, 2
- admission rate and lung damage: 1
- admission require and low fatality: 1, 2
- admission require and low fatality rate: 1
- admission require and low incidence: 1
- admission require and lung damage: 1, 2
Co phrase search for related documents, hyperlinks ordered by date